Skip to main content

Table 3 De novo type 2 diabetes at follow-up of liver transplant recipients with NASH

From: Risk of de novo post-transplant type 2 diabetes in patients undergoing liver transplant for non-alcoholic steatohepatitis

  NASH w/o DM Controls w/o DM Relative risk (95 % CI) p
Incidence of de novo DM at:     
6 months follow-up 499 (19.2 %) 1,737 (13.9 %) 1.38 (1.26–1.51) <0.0001
1 year follow-up 344 (14.3 %) 1144 (9.8 %) 1.46 (1.31–1.64) <0.0001
3 years follow-up 186 (11.4 %) 560 (6.8 %) 1.67 (1.43–1.96) <0.0001
5 years follow-up 73 (7.4 %) 275 (5.2 %) 1.43 (1.12–1.84) 0.0046
Had at least one onset of de novo post-transplant DM by:     
1 year follow-up 624 (22.9 %) 2,196 (16.7 %) 1.37 (1.27–1.49) <0.0001
3 years follow-up 578 (32.7 %) 2,004 (22.4 %) 1.46 (1.35–1.57) <0.0001
5 years follow-up 425 (39.8 %) 1,548 (27.0 %) 1.47 (1.35–1.61) <0.0001
Recorded resolution of post-transplant DM after the first onset 621 (73.8 %) 2,205 (74.7 %) 0.99 (0.94–1.03) 0.59
Time from onset to resolution, years 1.13 ± 1.06 1.07 ± 0.99   0.35
Long-term de novo post-transplant DM 174 (7.6 %) 481 (4.3 %) 1.76 (1.49–2.08) <0.0001
\